See the DrugPatentWatch profile for Tetrabenazine
Tetrabenazine, prescribed for chorea associated with Huntington's disease and tardive dyskinesia, may be financially burdensome for some patients due to its cost. Various programs offer copay assistance to help mitigate these expenses.
How can I find copay assistance for Tetrabenazine?
Patients seeking copay assistance for tetrabenazine can explore several avenues. The manufacturer of tetrabenazine, Lundbeck, offers a program called Lundbeck Patient Support [1]. This program provides resources for financial assistance, including copay savings cards, for eligible patients [1]. Other independent charitable organizations also exist to help individuals with prescription medication costs. A comprehensive search for these programs is recommended.
What is the Lundbeck Patient Support program?
The Lundbeck Patient Support program is designed to help patients access Lundbeck medications, including tetrabenazine. It offers a copay savings card program, which can reduce out-of-pocket costs for commercially insured patients. Eligibility requirements and program details may vary [1].
Are there other ways to reduce the cost of Tetrabenazine?
Beyond copay assistance, patients may consider patient assistance programs (PAPs) offered by the manufacturer or non-profit organizations if they meet certain income and insurance criteria [2]. Discussing alternative treatment options with a healthcare provider that may have lower associated costs is also a possibility.
What if I have commercial insurance and my tetrabenazine prescription is expensive?
Commercially insured patients can often benefit from copay savings cards, such as those provided by Lundbeck Patient Support [1]. These cards work by directly reducing the copay amount at the pharmacy. It is important to confirm with your insurance provider and the pharmacy about the specific savings card coverage for tetrabenazine.
Can people without insurance get help with tetrabenazine costs?
For uninsured patients, patient assistance programs (PAPs) are often the primary source of financial aid for prescription medications [2]. These programs aim to provide medications at little to no cost to eligible individuals who demonstrate significant financial need. The Lundbeck Patient Support program may also have options for uninsured patients [1].
How do I know if I qualify for copay assistance?
Qualification for copay assistance programs typically depends on factors such as insurance status, income level, and the specific program's guidelines. For the Lundbeck program, eligibility is generally for patients prescribed a Lundbeck product and who have commercial insurance. Specific details and income thresholds are usually outlined on the program's website or through their support line [1].
What is tardive dyskinesia and how does tetrabenazine help?
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. Tetrabenazine is a medication approved to manage these movements. It works by affecting dopamine levels in the brain, which are believed to play a role in the development of tardive dyskinesia.
What is chorea and how is tetrabenazine used for it?
Chorea is another movement disorder characterized by jerky, involuntary movements. Tetrabenazine is also approved to treat chorea associated with Huntington's disease. Similar to its use in tardive dyskinesia, it helps to reduce the frequency and severity of these involuntary movements by modulating dopamine pathways in the brain.
Are there any side effects of tetrabenazine I should be aware of?
Like all medications, tetrabenazine can have side effects. Common side effects may include drowsiness, fatigue, nausea, and insomnia. More serious side effects can occur, such as depression, suicidal thoughts, and parkinsonism (symptoms resembling Parkinson's disease). Patients should discuss potential side effects and their medical history with their doctor before starting tetrabenazine [3].
How long does tetrabenazine treatment typically last?
The duration of tetrabenazine treatment is determined by a patient's individual response to the medication and the management of their underlying condition. It is prescribed to manage chronic conditions like chorea associated with Huntington's disease and tardive dyskinesia, meaning treatment can be long-term, adjusted based on symptom control and tolerability.
Sources:
[1] https://www.lundbeck.com/us/patients/our-patient-support
[2] https://www.needymeds.org/patient-assistance-programs
[3] https://www.drugs.com/tetrabenazine.html